E cigs: Ends, Means & Distractions - Clive Bates Can we rely on the market to produce safe & effective e-cigs? - Martin Dockrell Why aren't we rejoicing about the success of e-cigs? - Charles Hamshaw-Thomas We should encourage smokers to try E-cigs - Dr Lynne Dawkins ">
Knowledge Action Change (KAC) and the London Drug and Alcohol Policy Forum (LDAPF) held a second dialogue on e-cigarettes, on Tuesday 10th September 2013, at the Guildhall, in the City of London.
This event followed the successful initial dialogue, in May 2012, also held at the Guildhall, which discussed the impact of new nicotine products on smoking.
The event was chaired by David MacKintosh, from the LDAPF with a series of short ‘position statements’ from a panel drawn from those who had been central to the debate to date, followed by a discussion involving everyone in the audience.
Panellists invited include:
Clive Bates, former Executive Director of ASH and prodigious blogger on all matters nicotine
Martin Dockrell, Director of Policy for ASH
David Dorn, mainstay of Vapourtrails TV, a formidable advocate of vaping
Lynn Dawkins, from the University of East London, who has done some very recent research into the use of e-cigarettes
Charlie Hamshaw-Thomas, Legal & Corporate Affairs Director E-Lites
Harm Reduction & E-cigs - David Dorn
E cigs: Ends, Means & Distractions - Clive Bates
Can we rely on the market to produce safe & effective e-cigs? - Martin Dockrell
Why aren't we rejoicing about the success of e-cigs? - Charles Hamshaw-Thomas
We should encourage smokers to try E-cigs - Dr Lynne Dawkins
Chair: Prof Gerry Stimson Respondent: Dr Delon Human, Health Diplomats, Switzerland
On 31st May 2012, the London Drug and Alcohol Policy Forum hosted the first KAC Dialogue on new ways of using nicotine, the health implications of new nicotine products, implications for changes in the tobacco industry.
Given the interest in tobacco harm reduction in the UK, the development of new nicotine products and the potential for the UK to lead in shaping new approaches to reducing the smoking of tobacco, this event provided an opportunity to explore and debate tobacco and nicotine futures.
It was held on World Health Organization No-Smoking Day.
Over 100 people participated including those involved in advocacy for tobacco control, those working in smoking cessation clinics, public heath planners, people working in addiction services, from government departments and in product regulation, from tobacco and nicotine companies, academic researchers, people in local authorities and primary care trusts, and people working for NGOs and charities.
K•A•C Dialogues are designed to advance knowledge and understanding of topical and often controversial issues. Through a combination of expert presentations, discussion and debate, our ambition is to create a forum for informed discussion of the future responses to drugs, alcohol and tobacco.